page

Test Index

1 2 3193 194 195 196 197527
Showing 19411950 of 5262 Items

Oliveda International, Inc. (OLVI) Acquires Ladope Inc. to Make CBD Frequencies and Energy Available Worldwide Via App and Strengthen Additionally the Effects of CBD Products in Cosmetics or Food Supplements

[SANTA MONICA, CA - (NewMediaWire) - July 30, 2019 - Oliveda International, Inc. (OTC Pink: OLVI), a leading international innovator in natural cosmetics and wearable beauty and health technology, today announced the acquisition of Ladope Inc. which makes CBD frequencies and energy available worldwide through a globally unique CBD technology delivered via app to strengthen additionally the effects of CBD products in cosmetics or food supplements., , NewMediaWire, Commenting on the acquisition, Oliveda founder Thomas Lommel stated, \u201cTwenty years ago, I had no idea about agriculture and olive trees, and today, we are the number one environmentalist in our region with more than 30,000 certified organic olive trees.\xa0, \u201cI did not know anything about cosmetics and something like eye creams and serums when I developed my first olive tree elixir in the legendary olive tree house in 2001. Today, we have not only one of the best eye creams and serums on the market, but a total of more than 70 products that unfold their effect from the inside out and from the outside in., \u201cI had no idea about therapies or meditation when I developed the olive tree therapy and olive tree meditation intuitively in the tree house. Today, the olive tree meditation is part of the olive tree therapy which is one of the most effective and holistic therapies of our time and can change life as confirmed from conventional medicine., \u201cOne of my biggest dreams; however, was to make Lommel's life-changing energy and information, \u201cmy trees,\u201d e.g. the frequencies of our mountain olive trees that I had treated myself with in 1997 and 1998, available to everyone in 2015. Then in 2015, we had our project Olive Tree People, the first frequencies sent from the mountain olive tree around the world., \u201cWe have accumulated a lot of knowledge and even more competence over the past two decades that will help us not only to participate in the enormous potential of the CBD industry, which is valued at over $22 billion, but also revolutionize the industry through our patent application on this globally unique CBD technology. As early as October 2019, we will be able to provide CBD frequencies across borders via app to anyone who wants it, free of charge, and also to increase the effect of CBD products such as cosmetics or supplements., \u201cIn the near future we will introduce you to the technology and products.\u201d, Oliveda International\xa0Inc.\xa0, Oliveda International\xa0Inc., Founded in 2003 by German real estate investor Thomas Lommel, Oliveda International, Inc. is a leading international natural cosmetic company in the premium segment.\xa0The company has also developed a globally-unique wearable beauty and health technology. In addition to online sales and a global branch network of 650 retail stores, the company\u2019s wholly owned Oliveda Deutschland GmbH subsidiary operates flagship stores, Olive Tree Pharmacy, in Berlin and Dusseldorf with plans to open new locations in Los Angeles, Taipei and Seoul.\xa0Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next five years. Through subsidiary operations, Oliveda International is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinos de Le\xf3, Spain.\xa0 Further information on Oliveda International can be found at\xa0http://www.oliveda.comand\xa0http://www.olivetreepeople.com.\xa0\xa0\xa0, http://www.oliveda.com, http://www.olivetreepeople.com, Forward-Looking Statements, Forward-Looking Statements, This press release may contain statements, estimates or projections that constitute "forward-looking statements" pursuant to the safe harbor provisions of the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. ...

Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2019

[SALT LAKE CITY, UT - (NewMediaWire) - July 30, 2019 - In the second calendar quarter (2Q) and first half (1H) of 2019, Utah Medical Products, Inc. (Nasdaq: UTMD) attained results which reflect that the Company remains on target to achieve its financial goals for year 2019 despite the apparent negative comparison with 2Q and 1H 2018 results.\xa0, , NewMediaWire, , Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; \xa3 or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and \u20ac or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted.\xa0, Summary of Financial ResultsIn USD terms, changes in 2Q and 1H 2019 consolidated income statement results compared to the same time periods in the prior calendar year were as follows:, Summary of Financial Results, , \xa02Q(April \u2013 June)1H(January \u2013 June)Sales:+ \xa08%+ 3%Gross Profit:+\xa0 7%+ 3%Operating Income:(11%)(14%)Net Income:(18%)(21%)Earnings Per Share:(18%)(20%), \xa02Q(April \u2013 June)1H(January \u2013 June)Sales:+ \xa08%+ 3%Gross Profit:+\xa0 7%+ 3%Operating Income:(11%)(14%)Net Income:(18%)(21%)Earnings Per Share:(18%)(20%), \xa02Q(April \u2013 June)1H(January \u2013 June), \xa0, 2Q(April \u2013 June), , (April \u2013 June), 1H(January \u2013 June), , (January \u2013 June), Sales:+ \xa08%+ 3%, Sales:, + \xa08%, + 3%, Gross Profit:+\xa0 7%+ 3%, Gross Profit:, +\xa0 7%, + 3%, Operating Income:(11%)(14%), Operating Income:, (11%), (14%), Net Income:(18%)(21%), Net Income:, (18%), (21%), Earnings Per Share:(18%)(20%), Earnings Per Share:, (18%), (20%), Financial results in 2Q 2019 continued to be hampered on the top line by a stronger USD, on the operating income line by the new intangible asset amortization expense from UTMD\u2019s February 2019\xa0 Filshie Clip System (Filshie device) U.S. exclusive distribution rights acquisition, and on the bottom line by a higher consolidated income tax provision rate than in 2018. \xa0Net income was also lower because UTMD had realized $450 in non-operating income from one-time sales of unneeded assets in 2Q 2018 which did not repeat in 2Q 2019., Because 29% of 1H 2019 consolidated sales were in foreign currencies, the volatility of foreign currency exchange (FX) rates for sales and expenses outside the U.S. (OUS) continued to have an impact on period-to-period relative financial results. FX rates for income statement purposes are transaction-weighted averages. The average rates from the applicable foreign currency to USD during 2Q 2019 and 1H 2019 compared to the same periods in 2018 follow:, \xa02Q 192Q 18Change1H 191H 18ChangeGBP1.2851.359(5.4%)1.2951.375(5.9%)EUR1.1251.192(5.6%)1.1291.209(6.6%)AUD0.7010.756\xa0 \xa0(7.3%)0.7070.771\xa0 (8.4%)CAD0.7480.775(3.5%)0.7500.783(4.1%), \xa02Q 192Q 18Change1H 191H 18ChangeGBP1.2851.359(5.4%)1.2951.375(5.9%)EUR1.1251.192(5.6%)1.1291.209(6.6%)AUD0.7010.756\xa0 \xa0(7.3%)0.7070.771\xa0 (8.4%)CAD0.7480.775(3.5%)0.7500.783(4.1%), \xa02Q 192Q 18Change1H 191H 18Change, \xa0, 2Q 19, 2Q 19, 2Q 18, 2Q 18, Change, Change, 1H 19, 1H 19, 1H 18, 1H 18, Change, Change, GBP1.2851.359(5.4%)1.2951.375(5.9%), GBP, 1.285, 1.359, (5.4%), 1.295, 1.375, (5.9%), EUR1.1251.192(5.6%)1.1291.209(6.6%), EUR, 1.125, 1.192, (5.6%), 1.129, 1.209, (6.6%), AUD0.7010.756\xa0 \xa0(7.3%)0.7070.771\xa0 (8.4%), AUD, 0.701, 0.756, \xa0 \xa0(7.3%), 0.707, 0.771, \xa0 (8.4%), CAD0.7480.775(3.5%)0.7500.783(4.1%), CAD, 0.748, 0.775, (3.5%), 0.750, 0.783, (4.1%), UTMD\u2019s revenues invoiced in the above foreign currencies represented 28.6% of total consolidated USD sales in 2Q 2019 and 29.2% in 1H 2019. The weighted average negative impact on all foreign currency sales from the change in FX rates was 5.6% in 2Q 2019 and 6.1% in 1H 2019, reducing reported USD sales in 2Q 2019 by $194 relative to the same FX rates in 2Q 2018 and by $431 in 1H 2019 relative to the same FX rates in 1H 2018.\xa0 In constant currency terms, i.e. using the same FX rates as in the applicable periods in 2018, total consolidated 2Q 2019 ...

newe

wqeqwe

abctest1

Lorem ipsum dolor sit amet abctest1abctest1abctest1abctest1abctest1abctest1abctest1

fdf

dfg

1 2 3193 194 195 196 197527
Showing 19411950 of 5262 Items